{"id":"placebo-and-zolpidem","safety":{"commonSideEffects":[{"rate":"5-10%","effect":"Dizziness"},{"rate":"5-10%","effect":"Drowsiness/somnolence"},{"rate":"5-10%","effect":"Headache"},{"rate":"<1%","effect":"Complex sleep behaviors"},{"rate":"<1%","effect":"Amnesia"},{"rate":"variable","effect":"Dependence/tolerance"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Zolpidem selectively binds to alpha-1 subunit-containing GABA-A receptors, enhancing the inhibitory effects of gamma-aminobutyric acid (GABA) and depressing central nervous system activity. This results in sedation and hypnotic effects that facilitate sleep initiation. The placebo component in this formulation serves as a control or comparative reference in clinical evaluation.","oneSentence":"Zolpidem is a sedative-hypnotic that binds to GABA-A receptors in the brain to promote sleep onset and maintenance.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:00:42.864Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Insomnia (sleep initiation and maintenance)"}]},"trialDetails":[{"nctId":"NCT05540574","phase":"PHASE2","title":"Trial of Zolpidem for Sleep in Children With Autism","status":"RECRUITING","sponsor":"Stanford University","startDate":"2023-08-09","conditions":"Autism, Autism Spectrum Disorder","enrollment":26},{"nctId":"NCT04118387","phase":"PHASE4","title":"Central Sleep Apnea : Physiologic Mechanisms to Inform Treatment","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2021-01-07","conditions":"Sleep Disordered Breathing, Able Bodied","enrollment":200},{"nctId":"NCT07420816","phase":"PHASE2","title":"Efficacy and Safety of APSTZD in the Treatment of Insomnia Disorder","status":"NOT_YET_RECRUITING","sponsor":"Apsen Farmaceutica S.A.","startDate":"2026-03-26","conditions":"Insomnia, Insomnia Chronic","enrollment":222},{"nctId":"NCT04014387","phase":"PHASE4","title":"Treatment of Disturbed Sleep in Progressive Supranuclear Palsy (PSP)","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2019-06-02","conditions":"Treatment","enrollment":40},{"nctId":"NCT03774810","phase":"PHASE4","title":"Partial Reinforcement II: Three Approaches to Maintenance Therapy for Chronic Insomnia","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2019-04-15","conditions":"Insomnia, Insomnia Chronic","enrollment":197},{"nctId":"NCT03375203","phase":"PHASE2","title":"A Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-42847922 in Participants With Insomnia Disorder","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2017-11-23","conditions":"Insomnia Disorders","enrollment":365},{"nctId":"NCT05106153","phase":"PHASE1","title":"A Study to Determine the Abuse Potential of Seltorexant Compared to Suvorexant and Zolpidem","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2021-12-17","conditions":"Healthy Non-dependent, Recreational Sedative Users, Abuse Potential","enrollment":127},{"nctId":"NCT04273776","phase":"EARLY_PHASE1","title":"A Comparison of the Physiological and Behavioral Effects of Suvorexant and Zolpidem in Healthy Volunteers: A Randomized, Double-blind, Placebo Controlled Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Walter Reed Army Institute of Research (WRAIR)","startDate":"2019-12-01","conditions":"Performance Enhancing Product Use","enrollment":90},{"nctId":"NCT05351541","phase":"PHASE1, PHASE2","title":"Psilocybin Therapy for Chronic Low Back Pain","status":"RECRUITING","sponsor":"Joshua Woolley, MD, PhD","startDate":"2023-12-01","conditions":"Chronic Low-back Pain","enrollment":30},{"nctId":"NCT03657212","phase":"PHASE4","title":"Enhancing Memory Consolidation in Older Adults","status":"TERMINATED","sponsor":"University of California, Irvine","startDate":"2018-10-01","conditions":"Aging","enrollment":10},{"nctId":"NCT02783729","phase":"PHASE3","title":"Study of the Efficacy and Safety of Lemborexant in Subjects 55 Years and Older With Insomnia Disorder (SUNRISE 1)","status":"COMPLETED","sponsor":"Eisai Inc.","startDate":"2016-05-31","conditions":"Insomnia","enrollment":1006},{"nctId":"NCT06685341","phase":"PHASE1","title":"PK/PD Study of YZJ-1139","status":"COMPLETED","sponsor":"Shanghai Haiyan Pharmaceutical Technology Co., Ltd.","startDate":"2019-03-07","conditions":"Insomnia","enrollment":20},{"nctId":"NCT05746143","phase":"PHASE4","title":"The Effect of Zolpidem on Outcomes Following Lumbar Spine Fusion","status":"RECRUITING","sponsor":"University of Southern California","startDate":"2022-02-01","conditions":"Spine Fusion, Lumbar Spine Degeneration, Pain, Postoperative","enrollment":140},{"nctId":"NCT03338764","phase":"PHASE3","title":"An Investigational Study to Assess Efficacy and Pattern of Use of SM-1 in Subjects With a History of Transient Insomnia","status":"WITHDRAWN","sponsor":"Sequential Medicine Ltd","startDate":"2023-05","conditions":"Transient Insomnia","enrollment":""},{"nctId":"NCT02456532","phase":"PHASE4","title":"Safety and Efficacy of Chronic Hypnotic Use 2","status":"COMPLETED","sponsor":"Henry Ford Health System","startDate":"2015-08-05","conditions":"Chronic Insomnia","enrollment":41},{"nctId":"NCT04692285","phase":"PHASE1","title":"Electrophysiological and Neuroimaging Correlates of the Effect of Zolpidem in Patients With Focal Dystonia","status":"COMPLETED","sponsor":"University Medical Centre Ljubljana","startDate":"2017-09-30","conditions":"Focal Dystonia","enrollment":24},{"nctId":"NCT05764798","phase":"PHASE1","title":"Shugan Jieyu Capsule for Insomnia Patients With Depressive Symptoms","status":"UNKNOWN","sponsor":"Nanfang Hospital, Southern Medical University","startDate":"2022-11-30","conditions":"Insomnia","enrollment":60},{"nctId":"NCT05615727","phase":"PHASE3","title":"Intranasal Dexmedetomidine and Zolpidem for Treatment of Primary Insomnia","status":"UNKNOWN","sponsor":"The University of Hong Kong","startDate":"2022-09-01","conditions":"Insomnia","enrollment":20},{"nctId":"NCT03885141","phase":"PHASE2, PHASE3","title":"Biolab Zolpidem Orodispersible 1.0 mg, 1.75 mg and 3.5 mg to Treat Maintenance Insomnia Disorder.","status":"UNKNOWN","sponsor":"Biolab Sanus Farmaceutica","startDate":"2021-03","conditions":"Insomnia Disorder","enrollment":366},{"nctId":"NCT03158025","phase":"PHASE1","title":"A Study to Determine the Abuse Potential of Single Oral Doses of Lemborexant Compared to Zolpidem, Suvorexant and Placebo in Healthy, Non-Dependent, Recreational Sedative Users","status":"COMPLETED","sponsor":"Eisai Inc.","startDate":"2017-04-19","conditions":"Insomnia Disorders","enrollment":39},{"nctId":"NCT02839200","phase":"PHASE2","title":"Efficacy and Safety of ACT-541468 in Adult Subjects With Insomnia Disorder","status":"COMPLETED","sponsor":"Idorsia Pharmaceuticals Ltd.","startDate":"2016-10-04","conditions":"Insomnia Disorder","enrollment":360},{"nctId":"NCT03621046","phase":"PHASE2","title":"Use of Low-dose Zolpidem in Parkinson's Disease","status":"COMPLETED","sponsor":"Aston University","startDate":"2018-08-20","conditions":"Parkinson Disease","enrollment":28},{"nctId":"NCT03297944","phase":"PHASE4","title":"Sedative-Anxiolytic Effects on Simulated Driving Performance","status":"COMPLETED","sponsor":"Marion Coe","startDate":"2017-09-15","conditions":"Psychomotor Impairment","enrollment":15},{"nctId":"NCT01463098","phase":"PHASE1","title":"A 2-Part Single Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2006","status":"COMPLETED","sponsor":"Eisai Inc.","startDate":"2011-10-05","conditions":"Insomnia","enrollment":122},{"nctId":"NCT03657355","phase":"PHASE1","title":"Study to Evaluate the Abuse Potential of ACT-541468 in Healthy Recreational Drug Users","status":"COMPLETED","sponsor":"Idorsia Pharmaceuticals Ltd.","startDate":"2018-09-07","conditions":"Healthy Recreational Drug Users","enrollment":63},{"nctId":"NCT03008447","phase":"PHASE1","title":"Crossover Study to Evaluate the Effect of Lemborexant Versus Placebo and Zolpidem on Postural Stability, Auditory Awakening Threshold, and Cognitive Performance in Healthy Subjects 55 Years and Older","status":"COMPLETED","sponsor":"Eisai Inc.","startDate":"2016-11-21","conditions":"Healthy Subjects","enrollment":60},{"nctId":"NCT03331042","phase":"PHASE3","title":"SM-1 vs 2 Comparators and Placebo in Participants With a History of Transient Insomnia.","status":"COMPLETED","sponsor":"Sequential Medicine Ltd","startDate":"2017-10-09","conditions":"Transient Insomnia","enrollment":85},{"nctId":"NCT01685073","phase":"PHASE2, PHASE3","title":"The Role of Sleep in the Treatment of Cannabis Use Disorders","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2012-09","conditions":"Drug Addiction","enrollment":127},{"nctId":"NCT02033707","phase":"PHASE1","title":"Effects of Hallucinogens and Other Drugs on Mood and Performance","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2014-04","conditions":"Healthy","enrollment":20},{"nctId":"NCT02484963","phase":"NA","title":"The Study of Spectrum of Sleep Disorders in Cirrhotic Patients and the Efficacy of Zolpidem in Cirrhotic Patients With Insomnia","status":"COMPLETED","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2015-05-15","conditions":"Cirrhosis","enrollment":52},{"nctId":"NCT03526575","phase":"PHASE4","title":"Optimize Astronaut Sleep Medication Efficacy and Individual Effects","status":"COMPLETED","sponsor":"National Aeronautics and Space Administration (NASA)","startDate":"2011-01-10","conditions":"Sleep, Cognition, Pharmacologic Actions","enrollment":34},{"nctId":"NCT02671760","phase":"PHASE2","title":"Pilot Study of a Combination Drug Product for Treatment of Short-term Insomnia","status":"COMPLETED","sponsor":"Sequential Medicine Ltd","startDate":"2016-02","conditions":"Short-term Insomnia","enrollment":39},{"nctId":"NCT02778659","phase":"NA","title":"Hypnotic Intake and Motor and Cognitive Performances at High Altitude","status":"COMPLETED","sponsor":"Centre d'Expertise sur l'Altitude EXALT","startDate":"2016-05","conditions":"Physiology","enrollment":22},{"nctId":"NCT02353299","phase":"PHASE4","title":"Assess the Effect of Zolpidem, Silenor & Placebo on Arousability, Ataxia/Balance & Cognition in Healthy Volunteers","status":"COMPLETED","sponsor":"Currax Pharmaceuticals","startDate":"2015-01","conditions":"Healthy","enrollment":52},{"nctId":"NCT00440323","phase":"PHASE1","title":"Disturbed Sleep Model Study.","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2007-01-05","conditions":"Sleep Initiation and Maintenance Disorders","enrollment":52},{"nctId":"NCT00662155","phase":"NA","title":"The Role of Partial Reinforcement in the Long Term Management of Insomnia","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2006-07","conditions":"Primary Insomnia","enrollment":129},{"nctId":"NCT00976105","phase":"PHASE1","title":"Effects of Repeat Dosing of GSK1521498","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2009-09-22","conditions":"Obesity","enrollment":49},{"nctId":"NCT00383643","phase":"PHASE2","title":"Xyrem(Sodium Oxybate) and Ambien(Zolpidem Tartrate) in the Treatment of Chronic Insomnia.","status":"COMPLETED","sponsor":"Stanford University","startDate":"2006-05","conditions":"Sleep Initiation and Maintenance Disorders","enrollment":48},{"nctId":"NCT00814502","phase":"NA","title":"Zolpidem CR and Hospitalized Patients With Dementia","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2008-12","conditions":"Dementia, Alzheimer Disease, Dementia, Vascular","enrollment":20},{"nctId":"NCT00653562","phase":"PHASE4","title":"Zolpidem (Myslee) Post Marketing Study in Adolescent Patients With Insomnia - Evaluation With Polysomnography","status":"COMPLETED","sponsor":"Astellas Pharma Inc","startDate":"2006-11","conditions":"Insomnia, Sleep Initiation and Maintenance Disorders","enrollment":11},{"nctId":"NCT00177216","phase":"PHASE4","title":"Characteristics of Sleep Patterns in Young Adults With and Without Insomnia","status":"COMPLETED","sponsor":"University of Pittsburgh","startDate":"2002-02","conditions":"Sleep Disorders","enrollment":69},{"nctId":"NCT02578472","phase":"PHASE1","title":"Pilot Study to Evaluate the Duration of Effects on Simulated Car Driving and Cognitive Performance After a Single Dose of JNJ-42847922, Zolpidem and Placebo in Healthy Participants","status":"COMPLETED","sponsor":"Janssen-Cilag International NV","startDate":"2015-11","conditions":"Healthy","enrollment":36},{"nctId":"NCT00608985","phase":"PHASE3","title":"Almorexant (ACT 078573) in Adult Subjects With Chronic Primary Insomnia","status":"COMPLETED","sponsor":"Midnight Pharma, LLC","startDate":"2008-03","conditions":"Primary Insomnia","enrollment":709},{"nctId":"NCT00781482","phase":"PHASE4","title":"Positron Emission Tomography Assessment of the Central Nervous System Effects of Eszopiclone and Zolpidem","status":"WITHDRAWN","sponsor":"Kettering Health Network","startDate":"","conditions":"Healthy","enrollment":""},{"nctId":"NCT01987739","phase":"PHASE1","title":"Study to Evaluate the Relative Abuse Potential of Almorexant in Recreational Drug Users","status":"COMPLETED","sponsor":"Midnight Pharma, LLC","startDate":"2009-09","conditions":"Abuse Potential Study","enrollment":42},{"nctId":"NCT00156533","phase":"PHASE4","title":"Long Term Treatment With Zolpidem: Nightly and Intermittent Dosing","status":"COMPLETED","sponsor":"University of Rochester","startDate":"2005-03","conditions":"Insomnia, Primary Insomnia, Psychophysiologic Insomnia","enrollment":20},{"nctId":"NCT01071889","phase":"PHASE1, PHASE2","title":"Safety and the Efficacy of a Sublingual Administration of Flumazenil to Reverse the Effect of Hypnotic Drugs in Healthy Adults","status":"COMPLETED","sponsor":"Coeruleus Ltd.","startDate":"2010-05","conditions":"Healthy","enrollment":10},{"nctId":"NCT01159652","phase":"PHASE4","title":"Hypnotic Medications and Memory: Effect of Drug Exposure During the Night","status":"COMPLETED","sponsor":"St. Luke's Hospital, Chesterfield, Missouri","startDate":"2010-10","conditions":"Sleep, Memory","enrollment":26},{"nctId":"NCT00374777","phase":"PHASE3","title":"A Double-blind, Group-comparison P-III Study With Zolpidem MR Using Placebo and Nitrazepam in Insomnia Patients","status":"COMPLETED","sponsor":"Astellas Pharma Inc","startDate":"2006-08","conditions":"Sleep Initiation and Maintenance Disorders","enrollment":450},{"nctId":"NCT00227942","phase":"PHASE4","title":"Estrogen for Treating Depression in Menopausal Women With Hot Flashes and Insomnia","status":"COMPLETED","sponsor":"Hadine Joffe, MD","startDate":"2003-08","conditions":"Sleep Initiation and Maintenance Disorders, Depression","enrollment":86},{"nctId":"NCT00936598","phase":"NA","title":"Sleep and Endometrial Cancer","status":"TERMINATED","sponsor":"University of Pittsburgh","startDate":"2009-07","conditions":"Sleep, Endometrial Neoplasms, Pain","enrollment":6},{"nctId":"NCT00893269","phase":"PHASE1","title":"The Effect of Marijuana and Prescription Medications in Mood, Performance and Sleep","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2008-10","conditions":"Marijuana Dependence","enrollment":36},{"nctId":"NCT00044629","phase":"PHASE2","title":"Combined Behavioral/Pharmacological Therapy for Insomnia","status":"COMPLETED","sponsor":"Duke University","startDate":"2001-09","conditions":"Sleep Initiation and Maintenance Disorders","enrollment":162},{"nctId":"NCT01920334","phase":"PHASE4","title":"Effects of Zolpidem CR® in Sleep and Heart Recovery in Cardiac Intensive Care Unit Patients","status":"UNKNOWN","sponsor":"Associação Fundo de Incentivo à Pesquisa","startDate":"2013-07","conditions":"Acute Coronary Syndrome, Sleep Deprivation","enrollment":100},{"nctId":"NCT01747590","phase":"EARLY_PHASE1","title":"Imaging the Effects of Zolpidem and Alprazolam in Healthy Volunteers at 3T","status":"UNKNOWN","sponsor":"Mclean Hospital","startDate":"2011-07","conditions":"Psychotropic Drugs Effects","enrollment":12},{"nctId":"NCT01351168","phase":"PHASE2","title":"Use of Zolpidem in Parkinson's Disease","status":"WITHDRAWN","sponsor":"Rush University Medical Center","startDate":"","conditions":"Parkinson's Disease","enrollment":""},{"nctId":"NCT01551485","phase":"NA","title":"Postoperative Sleep Disturbances After Zolpidem Treatment in Fast-track Hip and Knee Replacement","status":"UNKNOWN","sponsor":"Rigshospitalet, Denmark","startDate":"2012-02","conditions":"Sleep Duration on the First Night After Surgery","enrollment":20},{"nctId":"NCT00784875","phase":"PHASE2","title":"An Efficacy Study of Compound LY2624803 in the Treatment of Patients With Chronic Insomnia","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2008-10","conditions":"Primary Insomnia, Secondary Insomnia","enrollment":643},{"nctId":"NCT00568789","phase":"PHASE4","title":"Safety of Ramelteon in Elderly Subjects","status":"COMPLETED","sponsor":"Takeda","startDate":"2006-06","conditions":"Insomnia","enrollment":33},{"nctId":"NCT00086281","phase":"PHASE4","title":"Trial of Effects of Oral Xyrem and Zolpidem on Sleep-Disordered Breathing in Obstructive Sleep Apnea Patients","status":"COMPLETED","sponsor":"Jazz Pharmaceuticals","startDate":"2003-11","conditions":"Obstructive Sleep Apnea Syndrome","enrollment":60},{"nctId":"NCT00530556","phase":"PHASE4","title":"Insomnia and Daytime Function in Osteoarthritis","status":"COMPLETED","sponsor":"Sanofi","startDate":"2003-03","conditions":"Sleep Disorders","enrollment":170},{"nctId":"NCT01106859","phase":"PHASE1","title":"Driving Performance After Middle of the Night Administration of 3.5 mg Zolpidem Tartrate Sublingual Tablet","status":"COMPLETED","sponsor":"Transcept Pharmaceuticals","startDate":"2010-06","conditions":"Insomnia","enrollment":40},{"nctId":"NCT00466193","phase":"PHASE3","title":"A Study of Zolpidem Tartrate Sublingual Tablet in Adult Patients With Insomnia","status":"COMPLETED","sponsor":"Transcept Pharmaceuticals","startDate":"2007-05","conditions":"Insomnia","enrollment":295},{"nctId":"NCT00380081","phase":"PHASE3","title":"A Study of Zolpidem Tartrate Sublingual Tablet in Adult Patients With Insomnia","status":"COMPLETED","sponsor":"Transcept Pharmaceuticals","startDate":"2006-04","conditions":"Insomnia","enrollment":82},{"nctId":"NCT01280734","phase":"PHASE4","title":"Investigation of Melatonin and Zolpidem Effect on Postural Instability in Healthy Adult Subjects","status":"COMPLETED","sponsor":"Neurim Pharmaceuticals Ltd.","startDate":"2011-01","conditions":"Postural Instability","enrollment":26},{"nctId":"NCT01006525","phase":"","title":"Safety and Efficacy of Chronic Hypnotic Use","status":"COMPLETED","sponsor":"Henry Ford Health System","startDate":"2005-12","conditions":"Primary Insomnia","enrollment":116},{"nctId":"NCT00940550","phase":"PHASE1","title":"Study to Investigate the Effects of Melatonin, Temazepam & Zolpidem on Sleep EEG in Men and Women","status":"COMPLETED","sponsor":"University of Surrey","startDate":"2009-07","conditions":"Insomnia","enrollment":16},{"nctId":"NCT00492232","phase":"PHASE4","title":"Facilitation of Zolpidem (≥10 mg) Discontinuation Through Use of Ramelteon in Subjects With Chronic Insomnia","status":"COMPLETED","sponsor":"Takeda","startDate":"2007-04","conditions":"Chronic Insomnia","enrollment":135},{"nctId":"NCT00630175","phase":"PHASE3","title":"Evaluation of the Hypnotic Properties of Zolpidem-MR 12.5 mg and Zolpidem 10 mg Marketed Product Compared to Placebo in Patients With Primary Insomnia","status":"COMPLETED","sponsor":"Sanofi","startDate":"2003-09","conditions":"Sleep Initiation and Maintenance Disorders","enrollment":113},{"nctId":"NCT00716521","phase":"PHASE1","title":"Effect Of Treatment With Oral Zolpidem On Polysomnography And Actigraphy Measures In Healthy Volunteers","status":"COMPLETED","sponsor":"Pfizer","startDate":"2008-07","conditions":"Methodology Study","enrollment":11},{"nctId":"NCT00318448","phase":"PHASE3","title":"Efficacy, Safety, and Tolerability of Ambien (Zolpidem) in the Treatment of Children Ages 6 to 17 With Attention Deficit Hyperactivity Disorder (ADHD)-Associated Insomnia","status":"COMPLETED","sponsor":"Sanofi","startDate":"2006-04","conditions":"Attention Deficit Hyperactivity Disorder","enrollment":201},{"nctId":"NCT00425243","phase":"PHASE3","title":"Efficacy and Safety of Zolpidem-MR Administered Over a Long Term Period as Needed for Insomnia (ZOLONG)","status":"COMPLETED","sponsor":"Sanofi","startDate":"2004-08","conditions":"Sleep Initiation and Maintenance Disorders","enrollment":1025},{"nctId":"NCT00683436","phase":"PHASE2","title":"Efficacy and Safety Study of Adipiplon, Placebo and an Active Control in Primary Insomniacs","status":"TERMINATED","sponsor":"Neurogen Corporation","startDate":"2008-05","conditions":"Primary Insomnia","enrollment":84},{"nctId":"NCT00283790","phase":"PHASE4","title":"Residual Effects of Zolpidem Tartrate Extended Release and Eszopiclone Vs Placebo","status":"COMPLETED","sponsor":"Sanofi","startDate":"2006-01","conditions":"Insomnia","enrollment":36}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":420,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Ambien®"],"phase":"marketed","status":"active","brandName":"Placebo and zolpidem","genericName":"Placebo and zolpidem","companyName":"Takeda","companyId":"takeda","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Zolpidem is a sedative-hypnotic that binds to GABA-A receptors in the brain to promote sleep onset and maintenance. Used for Insomnia (sleep initiation and maintenance).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}